The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective study evaluating oral-only hormonal therapy with radiation for intermediate or high-risk prostate cancer in men age ≥ 70 years or with moderate comorbidity.
 
Benjamin Ernst Onderdonk
No Relationships to Disclose
 
Paige L. Dorn
No Relationships to Disclose
 
Fauzia Arif
No Relationships to Disclose
 
Daniel William Golden
Stock and Other Ownership Interests - HemOnc.org; RadOnc Questions
 
Theodore Karrison
No Relationships to Disclose
 
Sean P. Pitroda
Patents, Royalties, Other Intellectual Property - Patent entitled "Methods and kits for diagnosis and triage of patients with colorectal liver metastases" is pending. (Inst)
 
Russell Zelig Szmulewitz
Honoraria - Astellas Pharma
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi
Research Funding - Abbvie; Astellas Pharma; Incyte; Janssen Oncology; Macrogenics
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - Corcept Therapeutics
 
Stanley L. Liauw
No Relationships to Disclose